Monoclonal antibodies 13D9 and 6B9 are both specific for N-propionylated polysialic acid (NPrPSA); however, while 13D9 is protective against meningitis caused by group B meningococci and Escherichia coli capsular type K1 infection, 6B9 is not. The crystal structures of the Fabs from the two antibodies determined at 2.06 and 2.45 Å resolutions, respectively, reveal markedly different combining sites, where only the surface of 13D9 is consistent with the recognition of extended helical epitopes known to exist in the capsular polysaccharides of etiological agents of meningitis. Interestingly, complementarity determining region H2 on 13D9 lies in a non-canonical conformation that docking studies show is a critical feature in the generation of negative free energy of binding. Finally, the model of extended NPrPSA decasaccharide bound to 13D9 derived from docking studies is consistent with saturation transfer difference nuclear magnetic resonance experiments. Together, these results provide further evidence that extended epitopes have the ability to break immune tolerance associated with the polysialic acid capsule of these pathogens.
Introduction
The capsular polysaccharide of group B meningococci (GBMP) and Escherichia coli K1, which are both etiological agents of meningitis, consist of chains of α-(2,8)-linked sialic acid ( polysialic acid or PSA; Bhattacharjee et al. 1975) . Some of these PSA chains retain a phosphoglycolipid on their reducing termini (Gotschlich et al. 1981) , and although small, this lipid component causes the individual chains to aggregate resulting in the higher molecular weight GBMP (Gotschlich et al. 1981) . Despite this aggregation, the GBMP is still poorly immunogenic (Wyle et al. 1972; Jennings and Lugowski 1981) , probably because its major component PSA has been identified as a human tissue antigen (Finne et al. 1983; Troy 1992) . However, as GBMP is the only conserved antigenic structure on both target organisms, a vaccine based on the polysaccharide would be optimal. A novel approach (reviewed by Jennings et al. 1986 ) achieved this goal by replacing the N-acetyl groups of PSA by N-propionyl (NPr) groups. Vaccines composed of 10-11 kDa fragments of N-propionylated PSA (NPrPSA) conjugated to tetanus toxoid were able to induce high titers of NPrPSA-specific antibodies in mice (Jennings et al. 1986 ). Interestingly, these antibodies were both bactericidal for group B meningococci ) and passively protective against E. coli K1 , even though they did not cross-react with PSA (Jennings et al. 1987 . Thus, NPrPSA mimics a unique protective epitope on the surface of both organisms (Jennings et al. 1987 .
There is evidence to indicate that the protective epitope mimicked by NPrPSA is still associated with PSA but is only expressed in aggregated forms such as GBMP (Pon et al. 1997) . It has been suggested that PSA may be a component of the mimicked epitope ), but so far it has defied definitive description due to its complexity.
Previous inhibition studies on an NPrPSA-specific polyclonal antiserum have indicated that the protective epitope mimic was length-dependent ) and conformational in nature (Jennings et al. 1984) . This has the interesting consequence that antigen polymers much larger than the antibody-combining site actually bind most strongly, since longer segments have been shown to produce more conformational epitopes (Pon et al. 1997) . A helical epitope also is consistent with nuclear magnetic resonance (NMR) studies, which have suggested that the epitope was located on extended helical segments of the NPrPSA (Baumann et al. 1993 ) similar to the helical conformation previously proposed for the epitope of PSA (Kabat et al. 1988; Brisson et al. 1992; Evans et al. 1995) .
To characterize better the protective NPrPSA epitope, a series of NPrPSA-specific monoclonal antibodies (mAbs) were produced and screened against a number of NPrPSA antigens (Pon et al. 1997) . Consistent with previous inhibition experiments , it was found that the protective mAbs bind only to extended sequences of N-propionylneuraminic acid (Neu5Pr) and not to shorter segments such as (Neu5Pr) 4 (Pon et al. 1997) . Other mAbs obtained did bind to short segments of NPrPSA, but none was protective (Brisson et al. 1992) . To study the differences between these two types of antibodies, one mAb specific for an extended epitope (mAb 13D9) and one mAb for a short epitope (mAb 6B9) were selected for crystallographic analysis. Determining the differences in the combining sites of these antibodies is critical to understanding how each identifies NPrPSA.
Currently, no effective human polysaccharide vaccine against group B meningococci has been developed. The preclinical studies in both mice (Jennings et al. 1986 ) and non-human primates (Fusco et al. 1997) have indicated that an NPrPSA-protein conjugate would be an excellent vaccine candidate. A phase I clinical trial of a vaccine involving NPrGBMP conjugated to the tetanus toxin was performed on 17 healthy adult volunteers to investigate the safety and immunogenicity of the vaccine (Bruge et al. 2004 ). This trial confirmed that the vaccine induced IgG and IgM antibodies specific for the NPrGBMP; however, unlike the initial animal studies, no bactericidal antibodies were detected (Bruge et al. 2004) .
To gain further insight into the properties of the protective and non-protective antibodies, we have determined the structures of 13D9 and 6B9 to 2.06 and 2.45 Å resolution respectively. Although the crystallization of neither Fab in complex with its cognate antigen has been possible to date, docking experiments have combined the conformations of the NPrPSA antigens as determined by NMR (Baumann et al. 1993 ) with the high-resolution crystallographic structure of 13D9 in particular to yield a model of antibody recognition that has been validated against antigen-binding data collected by saturation transfer difference (STD) NMR.
Results

Gene segment analysis
The V L domain of 6B9 is derived from the recombination of V-region gene IGVK1-117 and the J-region gene IGKJ2, with three nucleotides inserted in the junction between the genes resulting in the amino acid sequence 88 CFQASHDPPTFG 99 over the complementarity determining region (CDR) L3 (Giudicelli et al. 2004) . The V H region of 6B9 is derived from the recombination V-region gene IGHV9-3, the D-region gene IGHD3-2 and the J-region gene IGHJ2, with three and four nucleotides inserted between the respective genes, resulting in the amino acid sequence 92 CARLRAVDYWG 104 over the CDR H3 (Giudicelli et al. 2004) .
The V L domain of 13D9 is derived from the recombination V-region gene IGVK4-63 and the J-region gene IGKJ1 with four nucleotides inserted in the junction between the genes resulting in the amino acid sequence 88 CFQGSGYPLTFG 99 over the CDR L3 (Giudicelli et al. 2004 (Giudicelli et al. 2004 ). mAb 6B9 crystal structure Data for the 6B9 Fab were collected to 2.45 Å resolution and refined to a final R work of 19.7% and R free of 27.9%, Table 1 . The structure showed excellent electron density along most of the polypeptide chain with the exception of amino acid residues 130-132 in the heavy chain constant region, which are disordered. A stereo view of the antigen-binding surface with the α-carbon backbone of the CDRs is shown in Figure 1 . All nonglycine residues are in or near the allowed regions of a Ramachandran plot with the exception of ValL51, SerH74, AlaH75, SerH134, AsnH155 and AspH173, all of which are remote from the combining site (Supplementary data, Figure S1 ). ValL51, part of CDR L2, lies in a classic gamma turn (a common feature in the floor of the combining site of many antibodies, Supplementary data, Figure S1 ). mAb 13D9 crystal structure Data for the 13D9 Fab were collected to 2.06 Å resolution, with final R work of 21.3% and R free of 28.6%, Table 1. The structure showed excellent electron density along most of the polypeptide chain. A stereo view of the antigen-binding surface with the α-carbon backbone of the CDRs is shown in Figure 1 . All non-glycine residues are in or near the allowed regions of a Ramachandran plot with the exception of ThrL51 and SerH134 (Supplementary data, Figure S1 ). SerH134 lies in the constant region far from the combining site, whereas ThrL51 lies in a classic gamma turn (Supplementary data, Figure S1 ). Antibodies specific for N-propionylated polysialic acid
Saturation transfer difference NMR
The experimental STD intensities of the NPrPSA decasaccharide binding to 13D9 clearly showed that the ligand was bound to the antibody ( Figure 2 ). A dipolar glycine deuterated buffer (Lane and Arumugam 2005) and use of a cryoprobe were needed to maximize the sensitivity of NMR experiments, so that the STD signals could be detected. Strong STD NMR signals were observed including the NPr-CH 2 and NPr-CH 3 resonances, suggesting that these groups were in contact with the antibody. The assignment of the proton transfer resonances in the NPr-sialic acid oligosaccharide is somewhat problematic in that all corresponding resonances from protons on individual residues cannot be resolved except for those of the reducing residue (Baumann et al. 1993) ; however, no STD NMR signals were observed for the reducing terminal, suggesting that this residue was not involved in binding. Hence, the observed STD intensities reflect the combined saturation transfer from all the residues in the antigen except the reducing one. The origin of the resonance at 3 ppm in the STD NMR difference spectrum is unknown ( Figure 2B ) and probably arises from the protein.
The experimental STD intensities were compared with the predicted ones using the coordinates of the protein-ligand complex with the polysaccharide antigen bound in an extended conformation, as well as those of the free protein and free ligand, by making use of the CORCEMA program. The calculated STD intensities for each position of the oligosaccharide were combined and presented as a net result for each position and compared with the observed STD intensities (Table 2) . Relative to NPr-CH 3 with a saturation time of 1.4 s and an average experimental error of ±20%. The experimental intensities are from integration of the resonances resulting for individual protons from residues 2-10. Other resonances are not listed, since spectral overlap prevented accurate integration of the signal intensities. The calculated intensity is the summation of the intensities for individual protons from residues 2-10. No STD NMR signals from the reducing residue were observed. The 6B9 combining site has a groove into which can fit the short unstructured NPrGBMP epitopes that are not protective for meningococci, whereas the 13D9 combining site has a convex surface that is consistent with the accommodation of long ( 10 residues) helix-like epitopes known to be protective for meningococci. The color code for CDRs is: CDR L1, red; L2, green; L3, blue; CDR H1, red; H2, green; H3, blue.
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Since no STD NMR signals could be observed for the reducing residue, it was not included in the calculations. Figure 2C presents the regions that the model predicts would exhibit the largest STD intensities. The strongest interaction is constrained to two regions of the ligand with the NPr moiety dominating for residues 4 and 7, which involve five of the six CDRs.
Discussion 13D9 CDR H2 lies in a non-canonical conformation The 6B9 Fab has been shown previously to recognize short NPrGBMP epitopes, which is a common antigen-recognition mode for carbohydrate-specific antibodies (Webb and Watkins 1959; Kabat 1960; Cisar et al. 1975 ). However, the 13D9 Fab is most unusual in that it has been shown to recognize exclusively long NPrGBMP epitopes (Brisson et al. 1992; Pon et al. 1997) . Remarkably, this includes polysaccharide chains that are far longer than the combining site, which is usually thought of being a maximum of eight residues (Webb and Watkins 1959; Jennings et al. 1984 Jennings et al. , 1985 . There is strong evidence that neither antibody binds terminal NPrPSA epitopes to pockettype sites (Pon et al. 1997) . Given that 13D9 is protective whereas 6B9 is not, 13D9 must achieve its protective ability by recognizing conformations of the antigen that are known to develop only with increasing chain length (Pon et al. 1997) . It was therefore expected that the determined conformations of the antigen-binding surfaces of the two Fabs would differ significantly.
The paratope of every antibody-combining site is determined by the composition and conformation of the six CDRs, three from the heavy and three from the light chain. Several years ago, the conformations of individual CDRs were grouped into "canonical" forms (Chothia and Lesk 1987; Chothia et al. 1989; Al-Lazikani et al. 1997; Morea et al. 1998) , where the conformation of each CDR could be assigned to one of a limited numbers of "families".
The CDRs in 6B9 all adopt canonical structures. Specifically, L1 contains a six-residue loop that creates β-sheet structure (L1 canonical structure 4, Al-Lazikani et al. 1997) that defines the edge of the concave binding site, Figure 1A . L2 is short and lies at the bottom of the site. L3 displays the most commonly observed canonical structure (L3 family 1), with a characteristic glutamine residue at position 90. (The side chain of GlnL90 inserts into the loop, displacing the main chain hydrogen bond interactions to give a short broad structure that forms part of the floor of the binding site.) H1 and H2 form part of the binding site wall, with H1 adopting the most commonly observed canonical structure 1, while H2 displays the canonical structure 2A with a single amino acid insertion after residue 52. H3 is worth special mention as it is a product of the joining of the heavy chain V-, D-and J-regions and displays much greater diversity generally compared to the other CDRs. H3 in 6B9 has only 11 amino acid residues, which is relatively short for this CDR and is the result of a two residue deletion between positions 98 and 101. The combination of the longer L1 and H2 CDRs with the short, broad conformations of the L3 and H3 CDRs generates a groove that could not accommodate extended helical epitopes of NPrGBMP, which is consistent with the lack of observed binding.
In contrast to 6B9, one CDR in 13D9 lies in a non-canonical conformation. CDR H2 in 13D9 contains a three-residue loop for which the only available canonical structure is family 4 (Al-Lazikani et al. 1997); however, the dihedral angles of the amino acid residues across H2 are significantly different from canonical family 4 (Table 3) . A comparison of the observed structure of H2 and the canonical form is given in Figure 3A . Antibodies specific for N-propionylated polysialic acid L1, L2, L3 and H1 in 13D9 each adopt their respective canonical structure 1. H3 also adopts a conformation common to this CDR (Morea et al. 1998) . The short CDRs L1, L2 and H1 combined with CDRs L3 and H3 to generate a convex surface with no extended binding cavity ( Figure 1B) . Interestingly, only CDR H2 extends beyond this convex surface.
Although the main chain density for all residues across H2 is unambiguous ( Figure 3B ), residues 52A-56 display significantly higher average temperature factors (55.3 for H2 vs 30.1 for all main chain atoms) and the side chains of residues LysH52B, IleH54 and TyrH55 are disordered. Such a high level of relative motion for H2 is remarkable for an anti-carbohydrate antibody due to the entropic penalties that are associated with immobilizing labile moieties during antigen binding.
The non-canonical form for H2 can be traced to the single somatic mutation NH54I (Giudicelli et al. 2004 ). Unlike asparagine, the side chain of IleH54 does not form stabilizing interactions with the rest of the protein, which allows the glycine residue at position H56 to provide H2 with much greater flexibility than is seen in other known Fab structures in the Protein Data Bank (Berman et al. 2000) . The dihedral angles adopted by GlyH56 in 13D9 lie in a region of the Ramachandran plot that would be disfavored for any other amino acid (Supplementary data, Figure S1 ; Table 3 ).
Modeling the antibody-antigen complex
All attempts to co-crystallize the two Fabs in the presence of their respective antigens have not yielded crystals of the liganded protein. However, manual docking was attempted of the helical NPrPSA epitopes (with its conformation determined by NMR) to the unliganded binding sites (as determined by X-ray crystallography) of both antibody fragments.
A conservative approach was taken with the docking experiments using coordinates of the Fab and coordinates of extended NPrPSA polymers obtained from NMR studies (Brisson et al. 1992; Henderson et al. 2003; Yongye et al. 2008 ) in an n = 9 helical structure (i.e. nine sugar residues per helical turn), where the protein main chain atoms were not adjusted and the dihedral angles of the glycosidic linkage minimally changed in order to maintain the extended structure of the antigen.
Comprehensive trials to fit manually the oligosaccharide helix to the binding surfaces of 6B9 failed to produce a complementary fit of antigen; but one such fit was found to 13D9. Refinement of this orientation predicted a net negative free energy of binding using AutoDock (Supplementary data, Table SI) .
AutoDock combines a simplified force field with an implicit water model to estimate the binding energy of the ligand and the protein of known structure. It is well suited for carbohydrate-protein complexes and for simple ligands where there is a low expected entropic penalty of binding, although more complex solvent structures can improve docking predictions (Gauto et al. 2013) . AutoDock has been shown to predict the free energy of binding within 3 kcal mol −1 per standard deviation (Cosconati et al. 2010) . Advanced statistical mechanics methods have provided more precise estimates of the free energy of binding (e.g. DeMarco and Woods 2008); however, these are computationally prohibitive. The free energy of binding for 13D9 to the n = 9 helical NPrPSA ligand of −7.2 kcal mol −1 (Supplementary data, Table SI) is negative enough to be significantly outside the expected error limit of AutoDock and indicates that the model is consistent with spontaneous binding.
Antibody-antigen complementarity
The complex model displays a high degree of complementarity of antibody to antigen, with each of nine consecutive sugar residues in contact with the protein surface ( Figure 4A ). Each saccharide residue is positioned to make from one to six hydrogen bonds to the antibody and displays no buried pockets capable of holding a solvent molecule (Table 4, Figure 4 ; Connolly 1981) .
There are 33 potential hydrogen bonds between the modeled antibody and antigen, with the majority made by the heavy chain, 6 of which are charged-residue interactions through sugar carboxylate groups ( Figure 4B ). This structure is consistent with a similar study for the binding of mAb735 to helical epitopes of α-(2,8)-linked PSA, where 30 potential hydrogen bond interactions between antibody and antigen can be made over the eight polysaccharide residues of the modeled epitope (Evans et al. 1995) .
Interestingly, the model shows that the novel non-canonical conformation of CDR H2 observed for this antibody is critical for recognition. Not only are three sugar residues positioned to make seven potential hydrogen bonds to this CDR in the noncanonical form, the minimization of the binding energies of the various models uniformly predicted that the binding of antigen to the protein with H2 in the canonical conformation would yield a positive (i.e. non-spontaneous) free energy of binding (not shown). Only models of the antibody fragment with H2 in the non-canonical form indicated by the X-ray diffraction study gave negative binding energies upon minimization.
STD NMR is consistent with an extended helical conformation STD NMR has been successfully employed to identify the protons of the carbohydrate that are proximal to the protein surface and so validate a proposed structural model using CORCEMA to calculate theoretical STD NMR intensities (DeMarco and Woods 2008; McNally et al. 2008) . In a related study, STD NMR has been used previously (and specifically) to validate 5 (PSA) binding in a helical conformation to endosialidase NF (Haselhorst et al. 2006 ). In our case, experimental STD NMR intensities for the NPrPSA decasaccharide binding to 13D9 and theoretical back-calculated STD NMR intensities using CORCEMA for the complex was consistent with the structural model and docking strategy used.
As the resonances for individual sialyl residues in the oligosaccharide (except for the reducing residue subunit 1, for which there were no observed STD NMR resonances) overlap and so not be resolved, it was not possible to determine directly from the STD NMR spectrum the particular subunits (2-10) that contribute significantly to binding the antibody. However, since the respective proton resonance from each subunit (2-10) have overlapping but distinct chemical shifts, it was possible to compare directly the calculated summation for residues 2-10 to the experimental STD NMR intensities for distinct chemical moieties.
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The calculated and observed STD intensities obtained for the structural model of the 13D9 antibody-oligosaccharide complex are shown in Table 2 . For the most part, the observed contributions to the STD NMR spectrum of the distinct chemical moieties in the antigen show excellent agreement with those predicted from the refined complex model and provide additional evidence of the binding of extended helical epitopes to 13D9.
Conclusions
The structures of the unliganded Fabs from a protective (13D9) and a non-protective (6B9) antibody have been determined to high resolution. The known antigenic conformations of the antigen were compared with the shapes of the combining sites of the two antibodies. The topology of 6B9 was not consistent with binding extended helical epitopes; however, the combining site of 13D9 was found to be complementary to extended epitopes of NPrPSA, in agreement with its known activity. Further, antibody 13D9 uses a non-canonical conformation for its H2 loop, which is necessary to form a complementary binding surface. The complex model displays a number of hydrogen bonds with the protein consistent with other modeled complexes and yielded calculated STD NMR intensities that agreed with the experimental studies. Residues are labeled "L" or "H" to correspond to the light and heavy chains, respectively. Antigen residues are shown in element coloring, with white for carbon, blue for nitrogen and red for oxygen. Antibody residues contacting the antigen are shown in green and potential hydrogen bonds in yellow. The NPrPSA polymer residues run from NPr1 (bottom) to NPr9 (top).
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Materials and methods
Purification and crystallization
The 6B9 and 13D9 Fabs were generated, purified and crystallized as described previously (Pon et al. 1997; Patenaude et al. 1998 ).
X-ray data collection X-ray diffraction data for the 6B9 Fab were collected as previously reported (Patenaude et al. 1998) at the A1 station of the Cornell High Energy Synchrotron Source (CHESS) at Cornell University. Data were reduced and merged using DENZO and SCALEPACK (Otwinowski and Minor 1997) .
Data for the 13D9 Fab were collected on a Rigaku RAXIS IV++ area detector at distances of 72 mm and exposure times of 5.0 min for 0.5°oscillations and processed with d*trek (Pflugrath 1999) . X-rays were produced by an MM-002 generator (Rigaku/MSC, The Woodlands, TX) coupled to Osmic "Blue" confocal X-ray mirrors with power levels of 30 W (Osmic, Auburn Hills, MI). The crystal was frozen and maintained under cryogenic conditions at a temperature of −160°C using a CryoStream 700 crystal cooler (Oxford Cryosystems, Devens, MA). The structures were solved by using molecular replacement techniques (Vagin and Teplyakov 1997) with the Fab from YsT9.1 (Evans et al. 1994 ) as a starting model and were subsequently refined using REFMAC5 (Murshudov et al. 2011) in the CCP4 program suite .
Manual docking
Initial computer-aided docking experiments were performed using PyMol (DeLano 2002), Figure 1 was made using PyMol (DeLano 2002) . Figures 3 and 4 were made using SetoRibbon (Evans, SV, unpublished) .
Energy minimization of the manually docked structure The refinement of the manually docked structure was performed using the Affinity program of the InsightII package (Accelrys, San Diego, 1995) . The program employed a Monte Carlo procedure in conjunction with an energy minimization of 300 steps using a conjugate gradient (Polak_Ribiere) method. For both the ligand and the receptor, atomic types and potentials were assigned using the CFF91 force field and a cellmultiple non-bond method was used by the program (Stouten et al. 1993; Luty et al. 1995) . During the calculation, only the ligand and the binding site atoms within a radius of 20 Å from the ligand's initial location were allowed to move. In this in vacuo docking, a ligand spatial confinement of 3 Å with a force constant of 100 kcal mol −1 Å −2 was used to avoid ligand drift away from the binding surface. In order to alleviate inappropriate atomic contacts, all atoms of the refined docked complex were then subjected to a 10,000-step energy minimization. The resulting docked structure was then used for an estimation of binding energy using the AutoDock4 program and its associated scoring-function python script (Morris et al. 1998; Huey et al. 2007) . Hydrogen bonds and torsion angles were recorded using InsightII.
STD NMR spectroscopy
To maximize NMR sensitivity, the mAb 13D9 dissolved in 500 mM glycine deuterated buffer in 99.9% D 2 O, pH 7.4 (Lane and Arumugam 2005) , was prepared by exchanging the antibody in 10 mM phosphate buffer ( pH 7.3, 300 mM NaCl) by repeated re-concentration (five times) using a Minicon 10,000 filter. NPrPSA (DP = 10) was dissolved in the glycine buffer and added to the mAb solution. The final concentration of 13D9 mAb was 2 mg 0.6 mL −1 (20.8 µM). The ratio of oligosaccharide to antibody-binding site was 10:1.
NMR experiments were performed on a Varian Inova 600 MHz spectrometer equipped with a Varian inverse triple resonance HCN cold probe. STD experiments were acquired as previously described (McNally et al. 2008 ) using a series of Gaussian pulses (300 Hz bandwidth, 6.3 ms) and saturation times ranging from 158 ms to 2.7 s. Water was suppressed using a double pulse field gradient spin-echo (DPFGSE) sequence (Stott et al. 1997) . Protein resonances were suppressed using a 20 ms T1ρ filter. Spectra using 2400 transients were acquired at 16°C to shift the water resonance. Longitudinal relaxation rates (T −1 ) for the oligosaccharide in D 2 O were measured at 600 MHz using the inversion recovery technique and processed using the standard Varian NMR software.
Calculation of STD intensities was performed using the CORCEMA-STD program (Jayalakshmi and Krishna 2002; Jayalakshmi and Rama Krishna 2004) . The protein and ligand coordinates for the calculations were taken from the model for the 13D9-oligosaccharide complex. Only amino acid residues for which at least one of the residue's protons was within 5 Å of a non-polar hydrogen atom of the oligosaccharide in the complex were included in the calculation. Amide N-H and hydroxyl protons were assumed to have undergone exchange in the deuterated buffer and were not included in the calculations. For intra-methyl group relaxation, the generalized order parameter S 2 was set to 0.25, while an S 2 value of 0.85 was used for methyl-X relaxation.
It is known that oligosaccharides of sialic acid do not have a well-defined structure in aqueous solution and exhibit complex molecular dynamics that cannot be represented by a single correlation time (Henderson et al. 2003) . Relaxation rates for the free ligand calculated by the CORCEMA-STD program assume a fixed free ligand structure and correlation time. The calculation was modified so that the calculated relaxation rates of the free ligand were scaled to the experimental T −1 values. The latter approach avoids biasing the predicted results because of an inaccurate representation of the free ligand structure and dynamics.
CORCEMA calculations require the dissociation constant of the complex, the ligand association and dissociation rate constants, which can be obtained from surface plasmon resonance , respectively, resulting in a K D of 200 µM. Although this indicates weak binding, strong STD signals indicated that the ligand was binding to the protein. The correlation time of the complex is also required for the calculations and a value of 5 ns gave a reasonable fit of the sialyl ring protons STD values. STD signal intensities were evaluated as 100 × [(I(0) j − I(t) j )/I(0) j ] with I(0) j and I(t) j corresponding to the intensity of proton j with and without saturation transfer during a saturation time t. Relative saturation transfer intensities are expressed as the ratio of the STD intensity of proton k in the ligand to that of the ligand NPr methyl protons. Results are given for only those protons for which resolved peaks are present in the STD spectrum.
Supplementary data
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